Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a new deployment/build of the page and does not change the study content.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a minor update to the study record metadata without altering study content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a small metadata update to the study record without altering substantive information.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page now indicates that recruitment has ended for participants. It adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment header formatting, with the revision noted as v3.6.0.SummaryDifference0.3%

- Check63 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a minor site update. This does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check84 days agoChange DetectedPage revision updated from v3.5.3 to v3.5.4. This indicates the study record has been updated to a newer revision of the page content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.